June 25, 2008

Statins are being looked at as a possible MS treatment. However, this small study concludes that combining statins with interferons may actually worsen MS.

Natco Pharma announced it has signed a licence and supply agreement with US-based Mylan for the global sale of generic version of Teva's patented 'Copaxone', a drug prescribed for multiple sclerosis.

I wonder how soon insurance companies are going to start substituting the generic?